ENO1, a key glycolytic enzyme, contributes to the known “Warburg effect” that is the high glycolytic rate of cancer cells, even in presence of oxygen, and necessary to support the biosynthetic requirements of uncontrolled proliferation [10]. This evidence concerns the gene ENO1 and cancer.